Goldman Sachs
ONCY

Goldman Sachs’s ONCOLYTICS BIOTECH INC ONCY Stock Holding History

Goldman Sachs’s Portfolio ONCY Stock Details ONCY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-31,737
Closed -$17K – 7500
2014
Q4 		$17K Sell
31,737
-25,392
-44% -$15.4K ﹤0.01% 7004
2014
Q3 		$33K Buy
57,129
+47,047
+467% +$59.6K ﹤0.01% 6917
2014
Q2 		$13K Buy
+10,082
New +$14.4K ﹤0.01% 6916

Other funds holding ONCY

Canada Pension Plan Investment Board
Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of Nova Scotia
Bank of Nova Scotia Toronto, Ontario, Canada $66.2B AUM 46.3% 1-Year Est. Return
VFS
VSR Financial Services Overland Park, Kansas $607M AUM 0.85% 1-Year Est. Return
NCCM
Nine Chapters Capital Management Short Hills, New Jersey $45.4M AUM 14.43% 1-Year Est. Return
SC
Scotia Capital Toronto, Ontario, Canada $26.8B AUM 33.07% 1-Year Est. Return
NFG
Next Financial Group Houston, Texas $1.52B AUM 20.14% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
CIBC World Market
CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return

Goldman Sachs's ONCY Position: Q1 2015 in Review

Goldman Sachs sold out of ONCOLYTICS BIOTECH INC (ONCY) in Q1 2015, closing a stake of 31,737 shares — an estimated $17K sold.

Goldman Sachs first reported a position in ONCY in Q2 2014 and held it in 3 quarters. The position peaked at $33K in Q3 2014. 29 funds tracked by Wall St. Rank hold ONCY as of Q1 2015.

  • Goldman Sachs reported no remaining ONCOLYTICS BIOTECH INC position as of Q1 2015 after selling out during the quarter.
  • Goldman Sachs sold 31,737 ONCOLYTICS BIOTECH INC shares in Q1 2015, an estimated $17K.
  • Goldman Sachs first reported a position in ONCOLYTICS BIOTECH INC in Q2 2014 and held it in 3 quarters.
  • Goldman Sachs's ONCOLYTICS BIOTECH INC position peaked at $33K in Q3 2014.
  • 29 funds tracked by Wall St. Rank held ONCOLYTICS BIOTECH INC as of Q1 2015.

Based on Goldman Sachs's 13F filing for Q1 2015, filed 15 May 2015.